|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Serum ferritin abnormal | 13.11.01.028 | 0.023325% | | Not Available |
| Thalassaemia beta | 01.04.03.002; 03.15.03.003 | 0.005831% | | Not Available |
| Urinary bladder haemorrhage | 24.07.01.086; 20.03.01.023 | 0.005831% | | Not Available |
| Kidney enlargement | 20.01.06.003 | 0.008747% | | Not Available |
| Concomitant disease progression | 08.01.03.064 | 0.003803% | | Not Available |
| Terminal state | 08.01.03.079 | 0.008747% | | Not Available |
| Neck mass | 15.03.02.007 | 0.005831% | | Not Available |
| Creatinine urine increased | 13.13.01.028 | 0.005831% | | Not Available |
| Hepatic siderosis | 14.13.03.005; 09.01.10.008 | 0.014578% | | Not Available |
| Acute chest syndrome | 22.06.03.004; 01.04.02.004; 24.03.08.006 | 0.034987% | | Not Available |
| Leukaemic infiltration pulmonary | 22.08.01.016; 16.01.03.007; 01.10.03.007 | 0.001521% | | Not Available |
| Cardiac infection | 02.01.05.002; 11.01.16.003 | 0.001521% | | Not Available |
| Clostridium difficile infection | 11.02.02.009 | - | - | Not Available |
| Growth hormone deficiency | 05.03.02.004 | 0.005831% | | Not Available |
| Hepatic infection | 11.01.18.008; 09.01.08.014 | 0.008747% | | |
| Gastric infection | 11.01.07.008; 07.19.03.003 | 0.005831% | | Not Available |
| Hepatic mass | 09.01.08.015 | 0.005831% | | Not Available |
| Cell death | 08.03.03.003; 14.11.02.005 | 0.005831% | | Not Available |
| Parvovirus infection | 11.05.15.001 | 0.005831% | | Not Available |
| Nephrogenic anaemia | 20.01.01.007; 01.03.04.001 | 0.005831% | | Not Available |
| Carnitine deficiency | 14.08.04.022 | 0.005831% | | Not Available |
| General physical condition abnormal | 13.15.01.040 | 0.008747% | | Not Available |
| Blast cell count increased | 13.01.03.008 | 0.005324% | | Not Available |
| Grip strength decreased | 13.15.01.041 | 0.005831% | | Not Available |
| Cardiac siderosis | 14.13.03.003; 02.04.01.007 | 0.003803% | | Not Available |
| Acute lymphocytic leukaemia recurrent | 16.01.01.003; 01.10.01.003 | 0.001521% | | Not Available |
| Graft versus host disease in liver | 12.02.09.029; 10.02.01.060; 09.01.07.033 | 0.001521% | | Not Available |
| Apparent death | 08.01.03.062 | 0.008747% | | Not Available |
| Oncologic complication | 16.32.03.025 | 0.001521% | | Not Available |
| Pure white cell aplasia | 01.03.03.013 | 0.005831% | | Not Available |
